4-(5-Fluoro-pyrimidin-2-yloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester
|
- $628 - $635
- Product name: 4-(5-Fluoro-pyrimidin-2-yloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester
- CAS: 1261231-00-8
- MF: C15H22FN3O3
- MW: 311.3518832
- EINECS:
- MDL Number:
- Synonyms:4-(5-Fluoro-pyrimidin-2-yloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester
4 prices
Selected condition：
Brand
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerChemenu
- Product numberCM491274
- Product descriptiontert-Butyl 4-(((5-fluoropyrimidin-2-yl)oxy)methyl)piperidine-1-carboxylate 97%
- Packaging1g
- Price$628
- Updated2026-05-20
- Buy
- ManufacturerChemenu
- Product numberCM491274
- Product descriptiontert-Butyl 4-(((5-fluoropyrimidin-2-yl)oxy)methyl)piperidine-1-carboxylate 97%
- Packaging1g
- Price$628
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11311658
- Product descriptiontert-Butyl4-(((5-fluoropyrimidin-2-yl)oxy)methyl)piperidine-1-carboxylate 97%
- Packaging1g
- Price$635
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11311658
- Product descriptiontert-Butyl 4-(((5-fluoropyrimidin-2-yl)oxy)methyl)piperidine-1-carboxylate 97%
- Packaging1g
- Price$635
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM491274 | tert-Butyl 4-(((5-fluoropyrimidin-2-yl)oxy)methyl)piperidine-1-carboxylate 97% | 1g | $628 | 2026-05-20 | Buy |
| Chemenu | CM491274 | tert-Butyl 4-(((5-fluoropyrimidin-2-yl)oxy)methyl)piperidine-1-carboxylate 97% | 1g | $628 | 2026-05-26 | Buy |
| Crysdot | CD11311658 | tert-Butyl4-(((5-fluoropyrimidin-2-yl)oxy)methyl)piperidine-1-carboxylate 97% | 1g | $635 | 2021-12-16 | Buy |
| Crysdot | CD11311658 | tert-Butyl 4-(((5-fluoropyrimidin-2-yl)oxy)methyl)piperidine-1-carboxylate 97% | 1g | $635 | 2026-05-26 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|